About 9,148 results

ALLMedicine™ Hyperparathyroidism Center

Research & Reviews  3,193 results

Is preoperative parathyroid localization necessary for tertiary hyperparathyroidism?
American Journal of Surgery; Wang R, Abraham P et. al.

May 18th, 2022 - The role of preoperative parathyroid localization for tertiary hyperparathyroidism(tHPT) is unclear. We reviewed our experience regarding the feasibility of parathyroidectomy without preoperative localization. This is a retrospective study of rena...

Changes in Bone Mineral Density After Parathyroidectomy and Their Relations With Bioche...
The American Surgeon; Xu Q, Kong N et. al.

May 17th, 2022 - To measure total type 1 serum amino-terminal propeptide procollagen (t-P1NP), β- type 1 cross-linked C-terminal telopeptide collagen (β-CTX), N-terminal osteocalcin (OC), and 25-(OH)-VD3 levels before parathyroidectomy (PTX) in patients with PHPT,...

Hypercalcaemia and hyperparathyroidism in surgical practice.
The British Journal of Surgery; Bateman K, Egan RJ

May 17th, 2022 - Hypercalcaemia and hyperparathyroidism in surgical practice.|2022|Bateman K,Egan RJ,|

Genotype-Phenotype Correlations in Asian Indian Children and Adolescents with Primary H...
https://doi.org/10.1007/s00223-022-00985-x 10.1159/000381622 10.1530/EJE-20-1119 10.1111/cen.13453 10.1038/nrdp.2016.33 10.1210/jc.2014-3659 10.1007/s12020-017-1322-5 10.1210/endrev/bnaa031 10.1210/jc.2017-01249 10.1210/jc.2008-2430 10.1111/j.1365-2265.2011.04059.x 10.1210/jc.2018-02789 10.1210/jc.2014-2000 10.11138/ccmbm/2017.14.1.060 10.1055/s-0030-1255106 10.1111/cen.14254 10.1053/j.ajkd.2008.11.017 10.1136/gutjnl-2012-302779 10.1086/301953 10.1210/jcem.83.3.4653 10.1093/hmg/6.7.1169 10.1111/j.1365-2265.2011.04184.x 10.1210/jc.2012-2789 10.1038/ng.2007.44 10.1056/NEJMoa031237 10.1016/j.ando.2009.09.004 10.4103/ijem.IJEM_53_20 10.1007/s12098-014-1442-3 10.4103/2230-8210.202034 10.4103/ijem.ijem_349_21 10.1007/s10689-016-9891-7 10.1055/a-1402-0183 10.1002/humu.21188 10.1002/path.1489 10.1038/ng1295-389 10.1111/cen.14211 10.1111/j.1365-2265.2010.03870.x 10.1210/jc.2004-1046 10.1046/j.1365-2265.1999.00729.x 10.1210/jcem.80.9.7673400 10.1210/jc.2008-2484 10.1210/jc.2013-3593 10.1002/ccr3.1074 10.1007/s40618-017-0710-2 10.1055/s-0034-1372058 10.1111/j.1440-1746.2011.06791.x
Calcified Tissue International; Sharma A, Memon S et. al.

May 15th, 2022 - Childhood and adolescent primary hyperparathyroidism (PHPT) is a very rare disease. Data on its molecular genetics are scarce. We performed a retrospective analysis (January 2000-January 2021) to determine the deleterious germline variants and gen...

Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in...
American Journal of Nephrology; Bishop CW, Strugnell SA et. al.

May 14th, 2022 - Obesity increases the risk of vitamin D insufficiency, which exacerbates secondary hyperparathyroidism in chronic kidney disease. Recent studies suggest that serum total 25-hydroxyvitamin D (25OHD) levels of ≥50 ng/mL are necessary to produce sign...

see more →

Guidelines  6 results

ACR Appropriateness Criteria® Parathyroid Adenoma.
Journal of the American College of Radiology : JACR; , Zander D et. al.

Nov 20th, 2021 - Hyperparathyroidism is defined as excessive parathyroid hormone production. The diagnosis is made through biochemical testing, in which imaging has no role. However, imaging is appropriate for preoperative parathyroid gland localization with the i...

New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of workin...
Journal of Nephrology; Bellasi A, Cozzolino M et. al.

Dec 20th, 2019 - Bone mineral abnormalities (defined as Chronic Kidney Disease Mineral Bone Disorder; CKD-MBD) are prevalent and associated with a substantial risk burden and poor prognosis in CKD population. Several lines of evidence support the notion that a lar...

National Osteoporosis Society vitamin D guideline summary.
Age and Ageing; Aspray TJ, Bowring C et. al.

Jul 31st, 2014 - The National Osteoporosis Society (NOS) published its document, Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management, in 2013 as a practical clinical guideline on the management of vitamin D deficiency in adult patients...

AME position statement: primary hyperparathyroidism in clinical practice.
Journal of Endocrinological Investigation; Zini M, Attanasio R et. al.

Jul 25th, 2012 - AME position statement: primary hyperparathyroidism in clinical practice.|2012|Zini M,Attanasio R,Cesareo R,Emmolo I,Frasoldati A,|therapeutic use,etiology,therapeutic use,therapeutic use,complications,diagnosis,drug therapy,surgery,etiology,blood,

European League Against Rheumatism recommendations for calcium pyrophosphate deposition...
Annals of the Rheumatic Diseases; Zhang W, Doherty M et. al.

Jan 11th, 2011 - To agree terminology and to develop recommendations for the diagnosis of calcium pyrophosphate deposition (CPPD). The European League Against Rheumatism (EULAR) CPPD Task Force, comprising 15 experts from 10 countries, agreed the terms and recomme...

see more →

Drugs  149 results see all →

Clinicaltrials.gov  123 results

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

May 11th, 2022 - A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of CTAP101 (calcifediol) Extended-Release Capsules to Treat Secondary Hyperparathyroidism in Subjects with Vitamin D Insuf...

Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Inte...

May 9th, 2022 - The investigators hypothesize that positron emission tomography with fluorocholline (F18-choline PET) will reduce the proportion of unnecessary invasive surgery decisions and that the higher cost of positron emission tomography versus MIBI scintig...

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment

May 6th, 2022 - This study was an open clinical trial conducted in Mexican women diagnosed with postmenopausal osteoporosis and hyperparathyroidism associated or not with hypovitaminosis D from the climacteric clinic of the regional hospital "1o de Octubre" of th...

Atorvastatin Effects On Arterial Stiffness In Hemodialysis

Apr 15th, 2022 - Cardiovascular disease (CVD) is the most common cause of morbidity and mortality among patients with end-stage renal disease (ESRD) on hemodialysis (HD). CVD are present since the early stages of chronic kidney disease (CKD) and reach around 30 to...

see more →

News  173 results

Surgery Shows No Survival, Morbidity Benefit for Mild Hyperparathyroidism

Apr 18th, 2022 - Patients who receive parathyroidectomy for mild primary hyperparathyroidism show no benefits in survival or morbidity, including fractures, cancer, or cardiovascular outcomes over more than 10 years, when compared with those not receiving the surg...

Expert Panel Develops Quality Indicators for Diagnosis and Treatment of Primary Hyperparathyroidism

Jan 13th, 2022 - NEW YORK (Reuters Health) - An expert panel has developed quality indicators (QIs) for the diagnosis and management for primary hyperparathyroidism (pHPT), which they hope will help optimize quality and cost-effectiveness of care for patients. "To...

Support for Early Surgery in Older Adults With Primary Hyperparathyroidism

Nov 30th, 2021 - NEW YORK (Reuters Health) - Parathyroidectomy is associated with a lower risk of fracture compared with non-surgical management among older adults with primary hyperparathyroidism (PHPT), a new study indicates. "PHPT contributes to the development...

Neuroendocrine Tumors Clinical Practice Guidelines (NCCN, 2021)

Sep 30th, 2021 - Updated clinical guidelines on the diagnosis and management of neuroendocrine and adrenal tumors were released in 2021 by the National Comprehensive Cancer Network (NCCN). The new version of the guidelines, published in the Journal of the National...

Hypercalcemia? When to Worry

Aug 10th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: We are back. Paul, what are we talking about today? Paul N. Williams: MD: We're going to be discussing our podcast on hypercalcemia with the wildly enthusiastic and incredibly smar...

see more →

Patient Education  15 results see all →